These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32315671)

  • 1. Inhibitory effect of IQ-1S, a selective c-Jun N-terminal kinase (JNK) inhibitor, on phenotypical and cytokine-producing characteristics in human macrophages and T-cells.
    Seledtsov VI; Malashchenko VV; Meniailo ME; Atochin DN; Seledtsova GV; Schepetkin IA
    Eur J Pharmacol; 2020 Jul; 878():173116. PubMed ID: 32315671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Directs effects of granulocyte-macrophage colony stimulating factor (GM-CSF) on adaptive immunogenesis.
    Seledtsov VI; Malashchenko VV; Gazatova ND; Meniailo ME; Morozova EM; Seledtsova GV
    Hum Vaccin Immunother; 2019; 15(12):2903-2909. PubMed ID: 31063025
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-Inflammatory Effects and Joint Protection in Collagen-Induced Arthritis after Treatment with IQ-1S, a Selective c-Jun N-Terminal Kinase Inhibitor.
    Schepetkin IA; Kirpotina LN; Hammaker D; Kochetkova I; Khlebnikov AI; Lyakhov SA; Firestein GS; Quinn MT
    J Pharmacol Exp Ther; 2015 Jun; 353(3):505-16. PubMed ID: 25784649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JNK selective inhibitor, IQ-1S, protects the mice against lipopolysaccharides-induced sepsis.
    Nie Z; Xia X; Zhao Y; Zhang S; Zhang Y; Wang J
    Bioorg Med Chem; 2021 Jan; 30():115945. PubMed ID: 33340939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of a novel class of c-Jun N-terminal kinase inhibitors.
    Schepetkin IA; Kirpotina LN; Khlebnikov AI; Hanks TS; Kochetkova I; Pascual DW; Jutila MA; Quinn MT
    Mol Pharmacol; 2012 Jun; 81(6):832-45. PubMed ID: 22434859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective Effects of a Novel Inhibitor of c-Jun N-Terminal Kinase in the Rat Model of Transient Focal Cerebral Ischemia.
    Plotnikov MB; Chernysheva GA; Smolyakova VI; Aliev OI; Trofimova ES; Sherstoboev EY; Osipenko AN; Khlebnikov AI; Anfinogenova YJ; Schepetkin IA; Atochin DN
    Cells; 2020 Aug; 9(8):. PubMed ID: 32784475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel c-Jun N-Terminal Kinase (JNK) Inhibitors with an 11
    Liakhov SA; Schepetkin IA; Karpenko OS; Duma HI; Haidarzhy NM; Kirpotina LN; Kovrizhina AR; Khlebnikov AI; Bagryanskaya IY; Quinn MT
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel dual NO-donating oxime and c-Jun N-terminal kinase inhibitor protects against cerebral ischemia-reperfusion injury in mice.
    Atochin DN; Schepetkin IA; Khlebnikov AI; Seledtsov VI; Swanson H; Quinn MT; Huang PL
    Neurosci Lett; 2016 Apr; 618():45-49. PubMed ID: 26923672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages.
    Budai MM; Varga A; Milesz S; Tőzsér J; Benkő S
    Mol Immunol; 2013 Dec; 56(4):471-9. PubMed ID: 23911403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective Effects of a New C-Jun N-terminal Kinase Inhibitor in the Model of Global Cerebral Ischemia in Rats.
    Plotnikov MB; Chernysheva GA; Aliev OI; Smol'iakova VI; Fomina TI; Osipenko AN; Rydchenko VS; Anfinogenova YJ; Khlebnikov AI; Schepetkin IA; Atochin DN
    Molecules; 2019 May; 24(9):. PubMed ID: 31058815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors.
    Schepetkin IA; Khlebnikov AI; Potapov AS; Kovrizhina AR; Matveevskaya VV; Belyanin ML; Atochin DN; Zanoza SO; Gaidarzhy NM; Lyakhov SA; Kirpotina LN; Quinn MT
    Eur J Med Chem; 2019 Jan; 161():179-191. PubMed ID: 30347329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive activity of a new c-Jun N-terminal kinase inhibitor in spontaneously hypertensive rats.
    Plotnikov MB; Aliev OI; Shamanaev AY; Sidekhmenova AV; Anishchenko AM; Fomina TI; Rydchenko VS; Khlebnikov AI; Anfinogenova YJ; Schepetkin IA; Atochin DN
    Hypertens Res; 2020 Oct; 43(10):1068-1078. PubMed ID: 32382155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct effects of interleukin-7 on the function of human T cells in vitro.
    Shmarov VA; Malashchenko VV; Meniailo ME; Gazatova ND; Todosenko NM; Melashchenko OB; Goncharov AG; Seledtsov VI
    Eur Cytokine Netw; 2016 Nov; 27(4):102-107. PubMed ID: 28396296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin Directly Affects Human Macrophage Functionality.
    Melashchenko OV; Meniailo ME; Malashchenko VV; Gazatova ND; Goncharov AG; Seledtsova GV; Seledtsov VI
    Curr Pharm Biotechnol; 2018; 19(11):902-909. PubMed ID: 30381071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct anti-inflammatory effects of granulocyte colony-stimulating factor (G-CSF) on activation and functional properties of human T cell subpopulations in vitro.
    Malashchenko VV; Meniailo ME; Shmarov VA; Gazatova ND; Melashchenko OB; Goncharov AG; Seledtsova GV; Seledtsov VI
    Cell Immunol; 2018 Mar; 325():23-32. PubMed ID: 29357983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype.
    Quero L; Hanser E; Manigold T; Tiaden AN; Kyburz D
    Arthritis Res Ther; 2017 Nov; 19(1):245. PubMed ID: 29096690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-8 favors pro-inflammatory activity of human monocytes/macrophages.
    Meniailo ME; Malashchenko VV; Shmarov VA; Gazatova ND; Melashchenko OB; Goncharov AG; Seledtsova GV; Seledtsov VI
    Int Immunopharmacol; 2018 Mar; 56():217-221. PubMed ID: 29414654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of c-Jun N-terminal kinase on lipopolysaccharide induced maturation of human monocyte-derived dendritic cells.
    Nakahara T; Uchi H; Urabe K; Chen Q; Furue M; Moroi Y
    Int Immunol; 2004 Dec; 16(12):1701-9. PubMed ID: 15477228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of p38 and CK2 Protein Kinases in the Response of RAW 264.7 Macrophages to Lipopolysaccharide.
    Glushkova OV; Parfenyuk SB; Novoselova TV; Khrenov MO; Lunin SM; Novoselova EG
    Biochemistry (Mosc); 2018 Jun; 83(6):746-754. PubMed ID: 30195331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Jun N-terminal kinase negatively regulates lipopolysaccharide-induced IL-12 production in human macrophages: role of mitogen-activated protein kinase in glutathione redox regulation of IL-12 production.
    Utsugi M; Dobashi K; Ishizuka T; Endou K; Hamuro J; Murata Y; Nakazawa T; Mori M
    J Immunol; 2003 Jul; 171(2):628-35. PubMed ID: 12847227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.